August 2026 Advocacy Update

As summer winds down, METAvivor’s Stage IV Stampede and Summit is approaching quickly, and we hope you’ll join us in Washington, DC. If you haven’t already, please mark your calendar […]

Support Legislation Removing Barriers to Clinical Trials

METAvivor signed onto a letter supporting the Clinical Trial Modernization Act. METAvivor has joined nearly 200 patient advocacy, public health, and health care organizations in supporting the bipartisan Clinical Trial […]

Letter from Alliance for Breast Cancer Policy

METAvivor Leads the Call for Better Cancer Registry Data As a proud Steering Committee member of the Alliance for Breast Cancer Policy, METAvivor was proud to sign on to this […]

June 11 PCORI Letter from METAvivor

METAvivor speaks out against proposed elimination of funding for the PCORI Trust Fund. PCORI’s patient-centered research fills a critical gap in the research landscape for the MBC community. Read the […]

June 11 Registries Letter from METAvivor

METAvivor is weighing in to make sure Congress supports America’s Cancer Registries as they set funding levels for 2027. Consistent and strong support for these registries is essential in our […]

Webinar Recap: The 4 Ws of Biomarker Testing

On October 29, METAvivor partnered with Menarini Group and Stemline to present The 4 Ws of Biomarker Testing, a powerful and informative webinar designed to demystify the role of biomarkers […]